phenylpropanolamine has been researched along with Attention Deficit Disorder with Hyperactivity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swann, AC | 1 |
| Nissen, SE | 1 |
| Boffi, BV; Klerman, GL | 1 |
1 review(s) available for phenylpropanolamine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Pharmacologic mood destabilization: case vignettes.
Topics: Adult; Affect; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Humans; Lamotrigine; Male; Middle Aged; Phenylpropanolamine; Propylamines; Rhinitis, Allergic, Seasonal; Triazines | 2009 |
2 other study(ies) available for phenylpropanolamine and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
ADHD drugs and cardiovascular risk.
Topics: Adult; Appetite Depressants; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Death, Sudden; Drug and Narcotic Control; Ephedra; Female; Humans; Male; Phenylpropanolamine; Sympathomimetics; United States; United States Food and Drug Administration | 2006 |
Manic psychosis associated with appetite suppressant medication, phenylpropanolamine.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Humans; Male; Phenylpropanolamine; Risk Factors | 1989 |